Tredegar Corporation (TG)

2 Stocks That May Benefit from Data Center Build-out

Tredegar Appoints Cindy Yao as Vice President, Chief Financial Officer and Treasurer

Arrowhead Pharmaceuticals Announces Interim Topline Clinical Data for the First Dual-Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia

Tredegar Announces Departure of Kevin Donnelly, Executive Vice President, General Counsel and Corporate Secretary

Tredegar Provides Update on One Tredegar Transformation

BlackRock Inc. Purchases New Position in Tredegar Corporation $TG

Connor Clark & Lunn Investment Management Ltd. Buys New Position in Tredegar Corporation $TG

Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia

Tredegar Announces Election of Ana Dutra to Board of Directors

Tredegar Q2 Earnings Rise Y/Y on Aluminum Extrusions Gains

Tredegar (NYSE:TG) Share Price Crosses Above 200 Day Moving Average – Here’s Why

Tredegar Reports Second Quarter 2026 Results

Tredegar Plans to Release Second Quarter 2026 Financial Results on August 7, 2026

Tredegar Announces the Retirement of Frasier W. Brickhouse II, Chief Financial Officer, Treasurer and Vice President, Effective September 1, 2026

Arrowhead Pharmaceuticals Reports Topline Results from Phase 3 SHASTA-3 and SHASTA-4 Studies of Plozasiran in Patients with Severe Hypertriglyceridemia